Dr. Timothy Savage

MD | Pediatric Infectious Diseases | Male

Dr. Timothy Savage, MD is a Boston, Massachusetts based Pediatric doctor with medical specialization in Pediatric Infectious Diseases. Current practice location of Dr. Timothy Savage is 300 Longwood Ave, Boston, Massachusetts - 02115. He can be contacted on phone at 617-355-6832. Dr. Timothy Savage is a sole proprietor of his business.
NPI number (Unique professional ID) for Dr. Timothy Savage is 1730507823 which was assigned by NPPES on 04 Apr, 2014 and it was last updated on 30 Jul, 2018. Dr. Timothy Savage license number is 274684 for Pediatrics Pediatric Infectious Diseases (2080P0208X) in Massachusetts.
Dr. Timothy Savage is trained to take care of children in the diagnosis, treatment and prevention of infectious diseases. Infectious Diseases pediatrician can apply specific knowledge to affect a better outcome for pediatric infections with complicated courses, underlying diseases that predispose to unusual or severe infections, unclear diagnoses, uncommon diseases and complex or investigational treatments.
Complete Profile:
Dr. Timothy Savage basic information including his official name, gender, specialization, credentials etc. are as mentioned below.
Specialization :Pediatrics Pediatric Infectious Diseases
Provider Name :Dr. Timothy Savage
Credential :MD
Gender :Male
Business Address:
Dr. Timothy Savage address, contact phone number and fax are as below. Patients can directly walkin to the clinic or can call on the below given phone number for appointment.
Primary Address :300 Longwood Ave
Boston, MA, 02115
United States
Phone Number :617-355-6832
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number : 1730507823
NPI Entity Type : Individual
First Enrolment Date : 04 Apr, 2014
Last Updated On : 30 Jul, 2018
Medicare Participation:
Dr. Timothy Savage participates in medicare and accepts medicare insurance either directly or through association with group practice or medical facility.
Medicare PECOS ID :1052632551
Medicare Enrollment ID :I20210628003034
Primary Specialty :Infectious Disease
Medical School :Icahn School Of Medicine At Mount Sinai
Graduation Year :2014
Accepts Medicare?Yes. Dr. Timothy Savage accepts medicare insurance.
Group Practice Association:
Dr. Timothy Savage is associated with following Group Practice Organizations. Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name with which Dr. Timothy Savage is associated with along with the number of members in that group. He may also accept medicare indirectly via these group practices.
Organisation Name :Group Practice IDNo. of MembersPractice AddressGroup Accepts Medicare
Children's Hospital Pediatric Associates, Inc3476541830231300 Longwood Ave
Boston, MA - 021155724
Ph: 6173556000
Yes
Licenses and Specialities:
Physicians/Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Timothy Savage are as mentioned. Primary taxonomy code for Dr. Timothy Savage, MD is 2080P0208X (Pediatrics Pediatric Infectious Diseases).
Taxonomy Code SpecialityPrimaryLicense No.State
208000000XPediatricsNo274684MA
2080P0208XPediatrics Pediatric Infectious DiseasesYes274684MA
Mailing Address:
Mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned business address only.
Mailing Address :300 Longwood Ave
Boston, MA, 02115-5724
United States
Phone Number :617-355-6832
Business Location:
Patients can refer following map for directions to Dr. Timothy Savage practice address. Don't forget to take prior appointment before visiting.

** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 January, 2024.